Esophageal Cancer: Beyond Current Treatments

Sharlin (Autor)

Buch | Softcover

154 Seiten

2024
tredition (Verlag)
978-3-384-22232-9 (ISBN)

Infos

Despite progress, esophageal cancer survival rates vary significantly. Early detection plays a crucial role. Unfortunately, symptoms like heartburn can be mistaken for less serious issues, leading to later diagnosis when the cancer is more aggressive. Additionally, socioeconomic factors can impact access to quality healthcare and optimal treatment options. Research also suggests disparities in screening and awareness between different demographics.Closing this survival gap requires a multi-pronged approach. Public awareness campaigns can educate people about early warning signs. Improved access to healthcare, particularly in underserved communities, is vital. Additionally, ongoing research into early detection methods and personalized treatment plans holds promise for narrowing the gap and offering a more hopeful future for all esophageal cancer patients.

Autor

Professor Sharlin is a distinguished scholar and thought leader in the field of psychology, specializing in criminal psychology, forensic psychology, and psychopathology. With over two decades of experience in academia, Prof. Sharlin has made significant contributions to the understanding of aberrant human behavior and the intricate workings of the criminal mind. Sharlin earned their Ph.D. in Psychology from a prestigious institution, where their groundbreaking research on psychopathy and personality disorders garnered widespread acclaim. Their doctoral thesis laid the foundation for their subsequent work, delving deep into the complexities of psychopathic behavior and its implications for society. Throughout their career, Prof. Sharlin has published extensively in top-tier academic journals, presenting cutting-edge research on topics ranging from criminal profiling to the neuroscience of aggression. Their work has not only advanced the academic discourse but has also informed real-world practices in law enforcement, criminal justice, and mental health. In addition to their scholarly achievements, Prof. Sharlin is a highly sought-after speaker and consultant, known for their engaging presentations and practical insights. They have been invited to lecture at leading universities, conferences, and professional workshops around the globe, sharing their expertise with students, researchers, and practitioners alike. Beyond their academic pursuits, Prof. Sharlin is deeply committed to mentorship and education, guiding the next generation of psychologists and forensic experts. They have supervised numerous graduate students and mentored aspiring researchers, nurturing talent and fostering innovation in the field. Overall, Prof. Sharlin's passion for understanding the darker facets of human nature and their dedication to advancing knowledge in psychology make them a respected authority and influential figure in the academic community.

Produkt-Details

• Erscheint lt. Verlag: 8.5.2024
• Verlagsort: hr
• Sprache: englisch
• Maße: 155 x 234 mm
• Gewicht: 269 g
• Themenwelt: Medizin / Pharmazie ► Gesundheitswesen
• Themenwelt: Medizinische Fachgebiete ► Chirurgie ► Viszeralchirurgie
• Schlagworte: Cancer care advancement • Clinical Trials • Emerging research • Esophageal cancer • Esophageal cancer management • Future of esophageal cancer treatment • Hope for patients • immunotherapy • Improving patient outcomes • Minimally Invasive Surgery • Multidisciplinary approach • novel therapies • Personalized medicine • targeted therapy • Treatment Options
• ISBN-10: 3-384-22232-6 / 3384222326
• ISBN-13: 978-3-384-22232-9 / 9783384222329
• Zustand: Neuware